Cardiology
News
Deferoxamine does not improve 90-day outcomes after ICH
HONOLULU – The drug is safe, and data suggest that it could improve 180-day outcomes.
News
SGLT2 inhibitors morph into HF drugs
“
News
Cilostazol plus aspirin or clopidogrel reduces the risk of recurrent stroke
HONOLULU – Dual therapy with cilostazol and aspirin or clopidogrel did not increase the risk of serious bleeding.
News
Intensive insulin added no benefit for hyperglycemia after ischemic stroke
Results from a large RCT showed intensive and standard insulin regimens produced similar clinical outcomes after an acute ischemic stroke.
News
Statins cut vascular events in elderly patients
Analysis challenges current practice of discontinuation after age 75 years.
Clinical
When is it safe to resume anticoagulation in my patient with hemorrhagic stroke?
Robust scientific data on when to resume anticoagulation after ICH does not exist.
News
AHA report highlights CVD burden, declines in smoking, sleep importance
Nearly half of Americans now have high blood pressure, in part due to the 2017 redefinition of hypertension.
News
Aspirin for primary cardiovascular prevention, RIP
SNOWMASS, COLO. – “Is aspirin safe and effective for primary prevention? The short answer here is no.” –Dr. Patrick T. O’Gara
News
Revised U.S. A fib guidelines revamp anticoagulation
The first revision of U.S. guidelines for managing atrial fibrillation since 2014 favor DOACs over warfarin.
News
Subclinical hypothyroidism boosts immediate risk of heart failure
CHICAGO – Large Danish study links subclinical and overt hypothyroidism to immediate risk of heart failure.